Analysts' Actions: ARNA, RIMM, C, ANF, SNDK

Tickers in this article: ANF ARNA BA C CCL NKE RIMM SNDK WFC

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Arena Pharmaceuticals downgraded at BMO to Market Perform, BMO Capital said. $10 price target. Valuation call, as the stock is up 170% since early May.

Boeing upgraded at Oppenheimer to Outperform from Perform, Oppenheimer said. $90 price target. 787 program has begun to find its footing.

Ball downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $44 price target.

Bancorp of New Jersey upgraded to buy at TheStreet Ratings.

CF Industries upgraded at Dahlman from Sell to Buy, Dahlman Rose said. Valuation call, based on a $200 price target.

EMCOR Group downgraded to hold at TheStreet Ratings.

Greif downgraded at JP Morgan from Overweight to Neutral JP Morgan said. Company has extensive exposure to Europe. $48 price target.

Heartland Payment upgraded at Wells from Neutral to Outperform, Wells Fargo said. $34 price target. Company will likely gain market share and expand margins.

Hubbell rated new Buy at KeyBanc with a Buy rating, KeyBanc said. $90 price target. Favorable end market exposure.

Kirby Corp downgraded at BofA Merrill to Neutral from Buy, Bank of America Merrill Lynch said. $56 price target. Costs above and synergies beyond reach.

Mosaic upgraded at Dahlman from Hold to Buy, Dahlman Rose said. Valuation call, based on a $60 price target.

Research in Motion downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. $7 price target. Book value will likely continue to decline.

Sandisk upgraded at Goldman to Buy, Goldman Sachs said. Supply/demand balance should return to normal by the fourth quarter. $45 price target.

Web.Com Group rated new Buy at Citigroup. $23 price target. Margins expansion from acquisition synergies.

STOCK COMMENTS / EPS CHANGES

Abercrombie & Fitch target lowered at Jefferies to $60, Jefferies said. Second quarter trends remain challenging. Buy rating.

Citigroup numbers lowered at Oppenheimer. Shares of C now seen reaching $48, Oppenheimer said. Estimates also lowered on another "risk off" quarter. Outperform rating.

Carnival numbers raised at Credit Suisse. Shares of CCL now seen reaching $33, Credit Suisse said. Estimates also increased through 2012. Neutral rating.

Kirby numbers lowered at Jefferies. Shares of KEX now seen reaching $70, Jefferies said. Estimates also lowered on lower guidance. Buy rating.

Nike numbers lowered at Jefferies. Shares of NKE now seen reaching $115, Jefferies said. Estimates also lowered on a decelerating sales environment. Buy rating.

Wells Fargo target lowered at Oppenheimer to $37, Oppenheimer said. Another "risk off" quarter. Outperform rating.

Watson Pharmaceuticals estimates raised at Citigroup. WPI estimates increased through 2013, Citigroup said. NEWCO estimates and AXR approval provide attractive entry point. $85 price target and Buy rating.

STRATEGY CALLS / MARKET CALLS

Global Handset Growth Cut at Goldman: Global mobile handset sales are now expected to grow just 4% in 2012, according to Goldman Sachs. Estimate for smartphone growth also reduced to 38%. Seeing lower demand in Western Europe, North America, China and Latin America.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:

>>Arena Pharma and the Fat Lady's Song

>>8 Post-Downgrade Bank Stock Bargains

Follow TheStreet on Twitter and become a fan on Facebook.

Tickers in this article: ANF ARNA BA C CCL NKE RIMM SNDK WFC